Annual musical event Bansuri Utsav will honour Zakir Hussain in its 16th edition, which is scheduled next month.

According to Vertex Pharmaceuticals, approximately 300 additional people with CF are now eligible to receive treatment.

The incidence of so-called “black lung disease” has been roaring back due to mechanized coal extraction technology.

Anna Podolanczuk, M.D., M.S., discusses how key epidemiological trends in idiopathic pulmonary fibrosis (IPF) and progressive pulmonary fibrosis (PPF), including changes in incidence and prevalence, ...

A $42,000 grant from NASA and INBRE will further CF research, through a collaborative effort spanning to India and the United Kingdom.

Researchers at National Jewish Health and colleagues have completed the first study comparing lung macrophages in multiple models of lung ...

The Food and Drug Administration (FDA) has approved Alyftrek ™ (vanzacaftor/tezacaftor/deutivacaftor) for the treatment of cystic fibrosis (CF) in patients aged 6 years and older who have at least one ...

Researchers at National Jewish Health and colleagues have completed the first study comparing lung macrophages in multiple models of lung injury. The research indicates that macrophages previously ...

Bexotegrast is under clinical development by Pliant Therapeutics and currently in Phase II for Liver Fibrosis.

GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes of the drug, ...